{"gene":"GNB3","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1998,"finding":"The C825T variant in exon 10 of GNB3 induces formation of a splice variant (Gβ3-s) in which nucleotides 498–620 of exon 9 are deleted, and this splice variant is associated with enhanced G-protein signal transduction activity in human cells and tissues.","method":"Molecular genotyping, splice variant characterization, functional signal transduction assays","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic link between SNP and splice variant described in multiple papers citing the original finding; single-lab origin but replicated in multiple subsequent studies referencing the same mechanism","pmids":["9856980","11927836","21709600"],"is_preprint":false},{"year":2002,"finding":"Healthy normotensive carriers of the GNB3 825T allele show significantly enhanced vasoconstriction responses to endothelin-1, angiotensin II, and noradrenaline in the skin microcirculation in vivo, demonstrating that the polymorphism modulates GPCR-mediated vascular tone.","method":"Laser Doppler flowmetry in vivo, pharmacological dose-response curves, NOS inhibition and alpha2-adrenoceptor antagonism to dissect mechanism","journal":"Pharmacogenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo physiological measurement with pharmacological dissection; single lab, multiple agonists and receptor pathway inhibitors","pmids":["12172218"],"is_preprint":false},{"year":2003,"finding":"The GNB3 825T allele is associated with enhanced nitroglycerin-induced venodilation in healthy men in vivo, suggesting G-protein (pertussis toxin-sensitive pathway) involvement in nitroglycerin signal transduction.","method":"Linear variable transducer technique measuring dorsal hand vein compliance; dose-response curves to nitroglycerin in subjects stratified by GNB3 genotype","journal":"Clinical Pharmacology and Therapeutics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method, pharmacological association study without direct biochemical confirmation of mechanism","pmids":["14586390"],"is_preprint":false},{"year":2003,"finding":"The GNB3 825CC genotype (lower signaling) is associated with enhanced platelet aggregation in response to low concentrations of GPCR agonists (ADP, thromboxane agonist U46619, epinephrine), and this effect is further enhanced cooperatively by the GPIIIa Pl(A2) allele.","method":"Turbidometric platelet aggregation assay with multiple agonists; genotyping by Pyrosequencing and restriction analysis in 150 individuals","journal":"Thrombosis Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional ex vivo platelet assay with multiple agonists and combinatorial genotype analysis; single lab","pmids":["12818251"],"is_preprint":false},{"year":2005,"finding":"The GNB3 825T allele is associated with impaired insulin-mediated venodilation in young healthy men in vivo, demonstrating that GNB3 genotype influences vascular insulin signaling.","method":"Linear variable transducer technique measuring dorsal hand vein compliance in response to insulin infusion, stratified by GNB3 C825T genotype; NOS3 genotype used as co-variable","journal":"Clinical Pharmacology and Therapeutics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method, functional vascular pharmacology study; no direct biochemical mechanism demonstrated","pmids":["15961981"],"is_preprint":false},{"year":2011,"finding":"In rge chickens, the D153del mutation in GNB3 targets the Gβ3 protein to early degradation (demonstrated by cycloheximide chase in COS-7 cells), leads to tissue-specific alterations in cGMP, cAMP, MAPK, AKT, and GRK2 phosphorylation cascades, and causes glomerulomegaly and tubulointerstitial inflammation in the kidney.","method":"Recombinant GNB3 constructs transfected into COS-7 cells with cycloheximide chase; secondary messenger quantification (cGMP, cAMP); kinase phosphorylation assays (MAPK, AKT, GRK2); kidney histochemistry","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutant vs wild-type protein plus cycloheximide chase establishing protein stability, combined with downstream signaling measurements and histopathological validation in vivo","pmids":["21887213"],"is_preprint":false},{"year":2013,"finding":"GNB3 is highly expressed in brain, retina, and heart ventricles; transgenic mice carrying an extra copy of GNB3 develop excess intraabdominal fat accumulation and weigh significantly more than wild-type littermates, establishing a causal role for GNB3 overexpression in obesity.","method":"BAC transgenic mouse model with extra copy of GNB3; body weight and body composition measurements compared to wild-type littermates; tissue expression analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic animal model with direct overexpression and quantitative metabolic phenotyping; replicated and extended in a subsequent study (PMID 29206867)","pmids":["23980137"],"is_preprint":false},{"year":2014,"finding":"Gβ3-null (GNB3−/−) mice show bradycardia during tail-cuff blood pressure measurements but normal body weight, metabolism, and blood pressure, including after angiotensin II infusion; isolated Gβ3-null hearts respond equivalently to muscarinic and β-adrenergic receptor stimulation, indicating Gβ3 is not directly involved in GPCR-controlled cardiac pacemaker activity.","method":"GNB3 knockout mouse model; metabolic phenotyping; tail-cuff blood pressure and heart rate measurements; angiotensin II infusion hypertension model; isolated perfused heart preparations; pharmacological receptor stimulation","journal":"Cellular Signalling","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout model with multiple orthogonal metabolic and cardiac physiological readouts including isolated organ preparations","pmids":["25093805"],"is_preprint":false},{"year":2016,"finding":"Biallelic loss-of-function mutations in GNB3 (compound heterozygous deletion/nonsense or homozygous nonsense/missense) cause a unique form of autosomal-recessive congenital stationary night blindness with dual anomaly: ON bipolar cell signaling defect and reduced cone sensitivity, establishing GNB3 as required for both cone phototransduction and ON bipolar cell signaling in humans.","method":"Whole-exome sequencing of affected families; ERG characterization of affected individuals; mutational screening of 58 CSNB subjects","journal":"American Journal of Human Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human genetics with multiple independent loss-of-function alleles confirmed by sequencing and functional ERG characterization; consistent with mouse knockout phenotype","pmids":["27063057"],"is_preprint":false},{"year":2016,"finding":"A homozygous GNB3 nonsense mutation (c.124C>T; p.Arg42Ter) causes recessive inherited retinal disease in humans characterized by nystagmus and macular disturbance, consistent with GNB3 being essential for cone photoreceptor and ON-bipolar cell function.","method":"Whole-exome sequencing; detailed retinal phenotyping including retinal imaging","journal":"JAMA Ophthalmology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single case with definitive loss-of-function allele and phenotypic characterization; consistent with parallel human genetics study (PMID 27063057)","pmids":["27281386"],"is_preprint":false},{"year":2017,"finding":"Transgenic mice carrying an extra copy of the human GNB3 825T risk allele develop increased adiposity, glucose intolerance, elevated fasting insulin and C-peptide (type 2 diabetes features), dyslipidemia, and lower UCP1 expression in white adipose tissue, without increased food intake or altered activity levels; this implicates GNB3 overexpression in dysregulated thermogenesis as a mechanism for obesity.","method":"BAC transgenic mouse model carrying human GNB3 825T allele; metabolic cage studies; glucose tolerance tests; plasma metabolite measurements; UCP1 gene expression in adipose tissue; behavioral battery","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 / Strong — controlled transgenic animal model with multiple orthogonal metabolic readouts and mechanistic follow-up (UCP1 expression), replicating and extending prior mouse overexpression study (PMID 23980137)","pmids":["29206867"],"is_preprint":false},{"year":2012,"finding":"The GNB3 825CC genotype is associated with significantly enhanced platelet aggregation in response to multiple GPCR agonists (TRAP, ADP, TXA2 agonist U46619, epinephrine) in whole blood impedance aggregometry, independently of the GPIIIa Pl(A) polymorphism, establishing GNB3 genotype as an independent determinant of platelet GPCR signaling.","method":"Impedance aggregometry (Multiplate) in whole blood from 143 individuals; multiple agonist concentrations; genotyping by Pyrosequencing and restriction analysis; multiple regression analysis","journal":"Pharmacogenetics and Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional ex vivo platelet assay with multiple agonists and regression analysis; single lab, replicates prior finding (PMID 12818251)","pmids":["22082654"],"is_preprint":false},{"year":2002,"finding":"Molecular modelling of GNB3 pre-mRNA secondary structures reveals marked differences between the C-haplotype and T-haplotype that may account for alternative splicing predominantly observed with the T-haplotype; six novel SNPs were identified defining two major GNB3 haplotypes across ethnic populations.","method":"Systematic gene sequencing for SNP discovery; genotyping in Caucasian, African, and Asian populations; computational RNA secondary structure modelling","journal":"Pharmacogenetics","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational modelling of RNA structure without experimental validation of splicing mechanism","pmids":["11927836"],"is_preprint":false}],"current_model":"GNB3 encodes the β3 subunit of heterotrimeric G proteins; a C825T variant in exon 10 drives alternative splicing to produce a truncated Gβ3-s variant with enhanced signal transduction, while biallelic loss-of-function mutations cause autosomal-recessive congenital stationary night blindness by disrupting both cone phototransduction and ON-bipolar cell signaling; GNB3 overexpression in transgenic mice causes obesity and metabolic syndrome associated with impaired thermogenesis (reduced UCP1 in white adipose tissue), whereas GNB3 knockout mice are metabolically normal but show bradycardia; the 825T allele also modulates GPCR-mediated vascular responses (enhanced vasoconstriction to endothelin-1, angiotensin II, and noradrenaline) and platelet aggregation via downstream G-protein signaling pathways."},"narrative":{"mechanistic_narrative":"GNB3 encodes the Gβ3 subunit of heterotrimeric G proteins and functions as a transducer of GPCR signaling across vascular, hematologic, retinal, and metabolic tissues [PMID:21887213, PMID:23980137]. A clinically important C825T variant in exon 10 drives an alternative splicing event that deletes exon 9 nucleotides 498–620 to generate a truncated Gβ3-s variant associated with enhanced signal transduction [PMID:9856980, PMID:11927836, PMID:21709600]. This altered signaling output is reflected physiologically: 825T carriers show enhanced GPCR-mediated vasoconstriction to endothelin-1, angiotensin II, and noradrenaline [PMID:12172218], while the 825CC genotype is associated with enhanced platelet aggregation to GPCR agonists including ADP, U46619, and epinephrine, independently of the GPIIIa Pl(A) polymorphism [PMID:12818251, PMID:22082654]. Loss-of-function studies establish the protein's essential roles: in chickens, the D153del mutation destabilizes Gβ3 and perturbs cGMP, cAMP, MAPK, AKT, and GRK2 signaling [PMID:21887213], and in humans biallelic loss-of-function mutations cause autosomal-recessive congenital stationary night blindness with combined cone phototransduction and ON-bipolar cell signaling defects [PMID:27063057, PMID:27281386]. GNB3 dosage controls metabolism: transgenic mice carrying an extra copy develop obesity, increased adiposity, and glucose intolerance with reduced UCP1 in white adipose tissue, implicating impaired thermogenesis, whereas Gβ3-null mice are metabolically normal but bradycardic [PMID:23980137, PMID:29206867, PMID:25093805].","teleology":[{"year":1998,"claim":"Established the molecular consequence of the common C825T variant, answering how a synonymous-region SNP could alter G-protein function by linking it to a truncated splice variant with enhanced signaling.","evidence":"Molecular genotyping with splice variant characterization and functional signal transduction assays in human cells/tissues","pmids":["9856980","11927836","21709600"],"confidence":"Medium","gaps":["Biochemical mechanism by which Gβ3-s enhances signaling not resolved","Quantitative contribution of the splice variant in different tissues unknown"]},{"year":2002,"claim":"Tested whether the C825T variant produces measurable in vivo vascular consequences, showing it modulates GPCR-mediated vascular tone across multiple agonist pathways.","evidence":"Laser Doppler flowmetry in vivo with pharmacological dose-response and receptor pathway inhibition in 825T carriers","pmids":["12172218"],"confidence":"Medium","gaps":["Does not establish a direct biochemical link between Gβ3-s and the enhanced vasoconstriction","Single lab; receptor-specific contributions not fully dissected"]},{"year":2002,"claim":"Sought a structural basis for the genotype-specific splicing, proposing that haplotype-dependent pre-mRNA secondary structure differences favor exon skipping with the T-haplotype.","evidence":"SNP discovery, multi-ethnic genotyping, and computational RNA secondary structure modelling","pmids":["11927836"],"confidence":"Low","gaps":["Computational only; no experimental validation of the proposed splicing mechanism","Causal SNP within the haplotype not isolated functionally"]},{"year":2003,"claim":"Extended the functional readout of GNB3 genotype to platelets, showing the 825CC genotype enhances GPCR-agonist-induced aggregation and cooperates with the GPIIIa Pl(A2) allele.","evidence":"Turbidometric platelet aggregation with multiple agonists and combinatorial genotyping in 150 individuals","pmids":["12818251"],"confidence":"Medium","gaps":["Mechanism linking genotype to platelet signaling output not biochemically defined","Direction of effect (CC enhanced) contrasts with vascular 825T findings and is not mechanistically reconciled"]},{"year":2003,"claim":"Probed whether GNB3 genotype affects nitroglycerin signaling in veins, associating 825T with enhanced venodilation via a pertussis toxin-sensitive pathway.","evidence":"Dorsal hand vein compliance dose-response to nitroglycerin stratified by genotype","pmids":["14586390"],"confidence":"Low","gaps":["Single-lab pharmacological association without direct biochemical confirmation","Pathway involvement inferred, not demonstrated at the protein level"]},{"year":2005,"claim":"Tested whether GNB3 genotype influences vascular insulin signaling, associating 825T with impaired insulin-mediated venodilation.","evidence":"Dorsal hand vein compliance to insulin infusion stratified by genotype with NOS3 as covariate","pmids":["15961981"],"confidence":"Low","gaps":["Single method, no direct biochemical mechanism","Link to systemic metabolic phenotypes not established here"]},{"year":2011,"claim":"Provided direct evidence that a GNB3 mutation acts via protein destabilization and broad signaling perturbation, moving beyond association to a causal cellular and tissue mechanism.","evidence":"Recombinant wild-type vs D153del constructs in COS-7 with cycloheximide chase, second-messenger and kinase phosphorylation assays, and kidney histopathology in rge chickens","pmids":["21887213"],"confidence":"High","gaps":["Cascade alterations are correlative downstream readouts, not mapped to specific effectors","Chicken-specific findings not directly validated in mammalian retina or kidney"]},{"year":2013,"claim":"Established that GNB3 gene dosage causally drives obesity, demonstrating a metabolic role independent of the human genetic associations.","evidence":"BAC transgenic mouse with extra GNB3 copy, body weight and composition phenotyping, tissue expression analysis","pmids":["23980137"],"confidence":"High","gaps":["Molecular mechanism connecting Gβ3 dosage to adiposity not defined in this study","Tissue site of action for the metabolic effect not localized"]},{"year":2014,"claim":"Used a clean knockout to define what Gβ3 is dispensable for, showing it is not required for normal metabolism or GPCR-controlled cardiac pacemaking, isolating bradycardia as its loss-of-function cardiac phenotype.","evidence":"GNB3-null mice with metabolic and blood pressure phenotyping, angiotensin II hypertension model, and isolated perfused heart pharmacology","pmids":["25093805"],"confidence":"High","gaps":["Mechanism of bradycardia not explained","Asymmetry between overexpression (obesity) and knockout (normal metabolism) phenotypes unexplained"]},{"year":2016,"claim":"Established GNB3 as a human disease gene by showing biallelic loss-of-function causes congenital stationary night blindness with a dual retinal signaling defect, defining its essential role in cone phototransduction and ON-bipolar cell signaling.","evidence":"Whole-exome sequencing of affected families with ERG characterization and mutational screening; independent case with p.Arg42Ter nonsense allele and retinal imaging","pmids":["27063057","27281386"],"confidence":"Medium","gaps":["Distinct molecular pathways in cones versus ON-bipolar cells not separated","Genotype-phenotype correlation across alleles limited by case numbers"]},{"year":2017,"claim":"Refined the obesity mechanism by linking GNB3 825T overexpression to impaired thermogenesis, identifying reduced adipose UCP1 as a candidate driver of the metabolic syndrome phenotype.","evidence":"BAC transgenic mice carrying human GNB3 825T allele with metabolic cage studies, glucose tolerance tests, plasma metabolites, UCP1 expression, and behavioral battery","pmids":["29206867"],"confidence":"High","gaps":["Causal chain from Gβ3 dosage to UCP1 downregulation not mechanistically traced","Cell-autonomous versus systemic origin of the thermogenic defect unresolved"]},{"year":null,"claim":"How the C825T-encoded Gβ3-s variant biochemically enhances G-protein signaling, and how the same gene's dosage and loss-of-function produce divergent tissue-specific phenotypes (vasculature, platelets, retina, metabolism), remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural or reconstitution data defining Gβ3-s effector coupling","Direction-of-effect discrepancies between vascular (825T) and platelet (825CC) phenotypes unexplained","Mechanism linking Gβ3 dosage to adipose UCP1 and thermogenesis not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[5,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,5]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,3,5,11]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[8,9]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[6,10]}],"complexes":["heterotrimeric G protein"],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P16520","full_name":"Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3","aliases":["Transducin beta chain 3"],"length_aa":340,"mass_kda":37.2,"function":"Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P16520/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNB3","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNB3","total_profiled":1310},"omim":[{"mim_id":"617024","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H","url":"https://www.omim.org/entry/617024"},{"mim_id":"614492","title":"PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C","url":"https://www.omim.org/entry/614492"},{"mim_id":"610863","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4; GNB4","url":"https://www.omim.org/entry/610863"},{"mim_id":"607795","title":"PRE-mRNA-PROCESSING FACTOR 4; PRPF4","url":"https://www.omim.org/entry/607795"},{"mim_id":"607298","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13; GNG13","url":"https://www.omim.org/entry/607298"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":396.1}],"url":"https://www.proteinatlas.org/search/GNB3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P16520","domains":[{"cath_id":"2.130.10.10","chopping":"2-338","consensus_level":"high","plddt":97.2361,"start":2,"end":338}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16520","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16520-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16520-F1-predicted_aligned_error_v6.png","plddt_mean":97.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNB3","jax_strain_url":"https://www.jax.org/strain/search?query=GNB3"},"sequence":{"accession":"P16520","fasta_url":"https://rest.uniprot.org/uniprotkb/P16520.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16520/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16520"}},"corpus_meta":[{"pmid":"9856980","id":"PMC_9856980","title":"G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension.","date":"1998","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/9856980","citation_count":148,"is_preprint":false},{"pmid":"36105097","id":"PMC_36105097","title":"GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36105097","citation_count":130,"is_preprint":false},{"pmid":"12893983","id":"PMC_12893983","title":"Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism.","date":"2003","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/12893983","citation_count":80,"is_preprint":false},{"pmid":"11230982","id":"PMC_11230982","title":"Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction.","date":"2001","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11230982","citation_count":79,"is_preprint":false},{"pmid":"11927836","id":"PMC_11927836","title":"Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit.","date":"2002","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11927836","citation_count":77,"is_preprint":false},{"pmid":"17278960","id":"PMC_17278960","title":"The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls.","date":"2007","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/17278960","citation_count":64,"is_preprint":false},{"pmid":"11116112","id":"PMC_11116112","title":"Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction.","date":"2000","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/11116112","citation_count":53,"is_preprint":false},{"pmid":"21709600","id":"PMC_21709600","title":"The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression.","date":"2011","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21709600","citation_count":51,"is_preprint":false},{"pmid":"16139171","id":"PMC_16139171","title":"Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.","date":"2005","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16139171","citation_count":43,"is_preprint":false},{"pmid":"12172218","id":"PMC_12172218","title":"Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.","date":"2002","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/12172218","citation_count":43,"is_preprint":false},{"pmid":"27063057","id":"PMC_27063057","title":"Biallelic Mutations in GNB3 Cause a Unique Form of Autosomal-Recessive Congenital Stationary Night Blindness.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27063057","citation_count":41,"is_preprint":false},{"pmid":"17717746","id":"PMC_17717746","title":"Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia.","date":"2007","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17717746","citation_count":40,"is_preprint":false},{"pmid":"16284746","id":"PMC_16284746","title":"Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.","date":"2005","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/16284746","citation_count":38,"is_preprint":false},{"pmid":"20826553","id":"PMC_20826553","title":"Variation in GNB3 predicts response and adverse reactions to antidepressants.","date":"2010","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20826553","citation_count":36,"is_preprint":false},{"pmid":"19174793","id":"PMC_19174793","title":"Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3).","date":"2009","source":"The American journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/19174793","citation_count":35,"is_preprint":false},{"pmid":"12576843","id":"PMC_12576843","title":"Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: a pilot study.","date":"2003","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/12576843","citation_count":34,"is_preprint":false},{"pmid":"22791279","id":"PMC_22791279","title":"Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population.","date":"2012","source":"Genes & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/22791279","citation_count":33,"is_preprint":false},{"pmid":"17521439","id":"PMC_17521439","title":"Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach.","date":"2007","source":"BMC psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17521439","citation_count":32,"is_preprint":false},{"pmid":"17066084","id":"PMC_17066084","title":"Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans.","date":"2006","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/17066084","citation_count":31,"is_preprint":false},{"pmid":"15855877","id":"PMC_15855877","title":"Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes.","date":"2005","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15855877","citation_count":31,"is_preprint":false},{"pmid":"19687782","id":"PMC_19687782","title":"Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19687782","citation_count":31,"is_preprint":false},{"pmid":"10526907","id":"PMC_10526907","title":"825T allele of the G-protein beta3 subunit gene (GNB3) is associated with impaired left ventricular diastolic filling in essential hypertension.","date":"1999","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/10526907","citation_count":30,"is_preprint":false},{"pmid":"23980137","id":"PMC_23980137","title":"Mouse model implicates GNB3 duplication in a childhood obesity syndrome.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23980137","citation_count":30,"is_preprint":false},{"pmid":"22214232","id":"PMC_22214232","title":"The role of G protein gene GNB3 C825T polymorphism in HIV-1 acquisition, progression and immune activation.","date":"2012","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/22214232","citation_count":29,"is_preprint":false},{"pmid":"11244012","id":"PMC_11244012","title":"G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension.","date":"2001","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/11244012","citation_count":29,"is_preprint":false},{"pmid":"15033462","id":"PMC_15033462","title":"Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15033462","citation_count":26,"is_preprint":false},{"pmid":"17299380","id":"PMC_17299380","title":"Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities study.","date":"2007","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/17299380","citation_count":25,"is_preprint":false},{"pmid":"31137020","id":"PMC_31137020","title":"Single Nucleotide Polymorphisms in Chemosensory Pathway Genes GNB3, TAS2R19, and TAS2R38 Are Associated with Chronic Rhinosinusitis.","date":"2019","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31137020","citation_count":25,"is_preprint":false},{"pmid":"17066254","id":"PMC_17066254","title":"Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.","date":"2006","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/17066254","citation_count":25,"is_preprint":false},{"pmid":"27660894","id":"PMC_27660894","title":"Association of CLOCK, ARNTL, PER2, and GNB3 polymorphisms with diurnal preference in a Korean population.","date":"2016","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/27660894","citation_count":24,"is_preprint":false},{"pmid":"12818251","id":"PMC_12818251","title":"Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation.","date":"2003","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/12818251","citation_count":24,"is_preprint":false},{"pmid":"27281386","id":"PMC_27281386","title":"Recessive Retinopathy Consequent on Mutant G-Protein β Subunit 3 (GNB3).","date":"2016","source":"JAMA ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/27281386","citation_count":23,"is_preprint":false},{"pmid":"18192837","id":"PMC_18192837","title":"Effects of the C825T polymorphism of the GNB3 gene on body adiposity and blood pressure in fertile and menopausal women: a population-based study.","date":"2008","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/18192837","citation_count":23,"is_preprint":false},{"pmid":"28225778","id":"PMC_28225778","title":"GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28225778","citation_count":22,"is_preprint":false},{"pmid":"18656447","id":"PMC_18656447","title":"Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18656447","citation_count":22,"is_preprint":false},{"pmid":"18793692","id":"PMC_18793692","title":"Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis.","date":"2008","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18793692","citation_count":21,"is_preprint":false},{"pmid":"27430937","id":"PMC_27430937","title":"Functional dyspepsia susceptibility is related to CD14, GNB3, MIF, and TRPV1 gene polymorphisms in the Greek population.","date":"2016","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/27430937","citation_count":20,"is_preprint":false},{"pmid":"16019105","id":"PMC_16019105","title":"GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection.","date":"2005","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/16019105","citation_count":20,"is_preprint":false},{"pmid":"16450155","id":"PMC_16450155","title":"Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers.","date":"2006","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16450155","citation_count":20,"is_preprint":false},{"pmid":"21371559","id":"PMC_21371559","title":"Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study.","date":"2011","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/21371559","citation_count":20,"is_preprint":false},{"pmid":"17136758","id":"PMC_17136758","title":"The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.","date":"2007","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17136758","citation_count":20,"is_preprint":false},{"pmid":"25451402","id":"PMC_25451402","title":"Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis.","date":"2014","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25451402","citation_count":19,"is_preprint":false},{"pmid":"20814328","id":"PMC_20814328","title":"C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients.","date":"2010","source":"Journal of clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20814328","citation_count":19,"is_preprint":false},{"pmid":"22408428","id":"PMC_22408428","title":"The -308G/A of Tumor Necrosis Factor (TNF)-α and 825C/T of Guanidine Nucleotide Binding Protein 3 (GNB3) are associated with the onset of acute myocardial infarction and obesity in Taiwan.","date":"2012","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22408428","citation_count":19,"is_preprint":false},{"pmid":"19420911","id":"PMC_19420911","title":"Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism.","date":"2009","source":"Annals of nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19420911","citation_count":19,"is_preprint":false},{"pmid":"11008983","id":"PMC_11008983","title":"G-protein beta3 subunit gene (GNB3) polymorphism 825C-->T in patients with hypertensive crisis.","date":"2000","source":"Critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11008983","citation_count":18,"is_preprint":false},{"pmid":"16908025","id":"PMC_16908025","title":"G-protein beta3 subunit (GNB3) gene polymorphisms and cardiovascular disease: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.","date":"2006","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/16908025","citation_count":18,"is_preprint":false},{"pmid":"20629643","id":"PMC_20629643","title":"Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population.","date":"2010","source":"Andrologia","url":"https://pubmed.ncbi.nlm.nih.gov/20629643","citation_count":18,"is_preprint":false},{"pmid":"15961981","id":"PMC_15961981","title":"Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3).","date":"2005","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15961981","citation_count":18,"is_preprint":false},{"pmid":"16493638","id":"PMC_16493638","title":"Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population.","date":"2006","source":"American journal of human biology : the official journal of the Human Biology Council","url":"https://pubmed.ncbi.nlm.nih.gov/16493638","citation_count":18,"is_preprint":false},{"pmid":"22222462","id":"PMC_22222462","title":"Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.","date":"2012","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22222462","citation_count":18,"is_preprint":false},{"pmid":"25510251","id":"PMC_25510251","title":"GNB3 and FTO Polymorphisms and Pregnancy Weight Gain in Black Women.","date":"2014","source":"Biological research for nursing","url":"https://pubmed.ncbi.nlm.nih.gov/25510251","citation_count":17,"is_preprint":false},{"pmid":"15019160","id":"PMC_15019160","title":"The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.","date":"2004","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15019160","citation_count":17,"is_preprint":false},{"pmid":"16513451","id":"PMC_16513451","title":"The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.","date":"2006","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16513451","citation_count":17,"is_preprint":false},{"pmid":"16139102","id":"PMC_16139102","title":"DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight.","date":"2004","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/16139102","citation_count":17,"is_preprint":false},{"pmid":"23691120","id":"PMC_23691120","title":"Interactions between the FTO and GNB3 genes contribute to varied clinical phenotypes in hypertension.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23691120","citation_count":16,"is_preprint":false},{"pmid":"17584726","id":"PMC_17584726","title":"Vasovagal syncope patients and the C825T GNB3 polymorphism.","date":"2007","source":"Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/17584726","citation_count":16,"is_preprint":false},{"pmid":"25093805","id":"PMC_25093805","title":"Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25093805","citation_count":15,"is_preprint":false},{"pmid":"14586390","id":"PMC_14586390","title":"Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3).","date":"2003","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/14586390","citation_count":15,"is_preprint":false},{"pmid":"28330327","id":"PMC_28330327","title":"Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.","date":"2016","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28330327","citation_count":14,"is_preprint":false},{"pmid":"15042113","id":"PMC_15042113","title":"GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate.","date":"2004","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/15042113","citation_count":14,"is_preprint":false},{"pmid":"14692527","id":"PMC_14692527","title":"The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia.","date":"2003","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/14692527","citation_count":14,"is_preprint":false},{"pmid":"16178055","id":"PMC_16178055","title":"Different genotype distribution of the GNB3 C825T polymorphism of the G protein beta3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell origin.","date":"2005","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16178055","citation_count":14,"is_preprint":false},{"pmid":"18783529","id":"PMC_18783529","title":"The associations among GNB3 C825T polymorphism, erectile dysfunction, and related risk factors.","date":"2008","source":"The journal of sexual medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18783529","citation_count":14,"is_preprint":false},{"pmid":"31768945","id":"PMC_31768945","title":"Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population.","date":"2019","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/31768945","citation_count":13,"is_preprint":false},{"pmid":"18058092","id":"PMC_18058092","title":"Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure.","date":"2007","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18058092","citation_count":13,"is_preprint":false},{"pmid":"16314202","id":"PMC_16314202","title":"GNB3 C825T and ACE I/D polymorphisms on the sodium-proton exchanger and the prevalence of essential hypertension in males.","date":"2006","source":"Archives of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/16314202","citation_count":12,"is_preprint":false},{"pmid":"15536455","id":"PMC_15536455","title":"Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.","date":"2004","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15536455","citation_count":12,"is_preprint":false},{"pmid":"29206867","id":"PMC_29206867","title":"GNB3 overexpression causes obesity and metabolic syndrome.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29206867","citation_count":11,"is_preprint":false},{"pmid":"24376503","id":"PMC_24376503","title":"GNB3, eNOS, and mitochondrial DNA polymorphisms correlate to natural longevity in a Xinjiang Uygur population.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376503","citation_count":11,"is_preprint":false},{"pmid":"27994504","id":"PMC_27994504","title":"Genetic Analysis of BDNF, GNB3, MTHFR, ACE and APOE Variants in Major and Recurrent Depressive Disorders in Russia.","date":"2016","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27994504","citation_count":11,"is_preprint":false},{"pmid":"25463071","id":"PMC_25463071","title":"GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study.","date":"2014","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/25463071","citation_count":11,"is_preprint":false},{"pmid":"19301222","id":"PMC_19301222","title":"Association of GNB3 C825T polymorphism with peak oxygen consumption.","date":"2009","source":"International journal of sports medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19301222","citation_count":11,"is_preprint":false},{"pmid":"29937877","id":"PMC_29937877","title":"Analysis of SNPs of MC4R, GNB3 and FTO gene polymorphism in obese Saudi subjects.","date":"2017","source":"African health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29937877","citation_count":10,"is_preprint":false},{"pmid":"21887213","id":"PMC_21887213","title":"The D153del mutation in GNB3 gene causes tissue specific signalling patterns and an abnormal renal morphology in Rge chickens.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21887213","citation_count":9,"is_preprint":false},{"pmid":"22882749","id":"PMC_22882749","title":"GNB3 C825T polymorphism is associated with postural tachycardia syndrome in children.","date":"2012","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/22882749","citation_count":9,"is_preprint":false},{"pmid":"24917685","id":"PMC_24917685","title":"Is gnb3 c825t polymorphism associated with elite status of polish athletes?","date":"2014","source":"Biology of sport","url":"https://pubmed.ncbi.nlm.nih.gov/24917685","citation_count":9,"is_preprint":false},{"pmid":"22258330","id":"PMC_22258330","title":"The C825T GNB3 polymorphism, independent of blood pressure, predicts cerebrovascular risk at a population level.","date":"2012","source":"American journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/22258330","citation_count":9,"is_preprint":false},{"pmid":"17559964","id":"PMC_17559964","title":"The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.","date":"2007","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/17559964","citation_count":9,"is_preprint":false},{"pmid":"16897596","id":"PMC_16897596","title":"The GNB3 C825T polymorphism and depression among subjects with alcohol dependence.","date":"2006","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/16897596","citation_count":9,"is_preprint":false},{"pmid":"24827746","id":"PMC_24827746","title":"Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial.","date":"2014","source":"Journal of medicinal food","url":"https://pubmed.ncbi.nlm.nih.gov/24827746","citation_count":9,"is_preprint":false},{"pmid":"16783490","id":"PMC_16783490","title":"Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G protein beta3 subunit (GNB3) C825T polymorphism.","date":"2006","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/16783490","citation_count":9,"is_preprint":false},{"pmid":"24477587","id":"PMC_24477587","title":"Multivariate meta-analysis of the association of G-protein beta 3 gene (GNB3) haplotypes with cardiovascular phenotypes.","date":"2014","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24477587","citation_count":8,"is_preprint":false},{"pmid":"21979884","id":"PMC_21979884","title":"Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism.","date":"2011","source":"Wiener klinische Wochenschrift","url":"https://pubmed.ncbi.nlm.nih.gov/21979884","citation_count":8,"is_preprint":false},{"pmid":"26856249","id":"PMC_26856249","title":"A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.","date":"2016","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/26856249","citation_count":8,"is_preprint":false},{"pmid":"22215956","id":"PMC_22215956","title":"Association of GNB3 C825T polymorphism with plasma electrolyte balance and susceptibility to hypertension.","date":"2011","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22215956","citation_count":8,"is_preprint":false},{"pmid":"20145952","id":"PMC_20145952","title":"Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme.","date":"2010","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20145952","citation_count":8,"is_preprint":false},{"pmid":"36017493","id":"PMC_36017493","title":"The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19).","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36017493","citation_count":7,"is_preprint":false},{"pmid":"22082654","id":"PMC_22082654","title":"The GNB3 C825T polymorphism influences platelet aggregation in human whole blood.","date":"2012","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/22082654","citation_count":7,"is_preprint":false},{"pmid":"27226707","id":"PMC_27226707","title":"Prediction of the Risk for Essential Hypertension among Carriers of C825T Genetic Polymorphism of G Protein β3 (GNB3) Gene.","date":"2016","source":"Biomarker insights","url":"https://pubmed.ncbi.nlm.nih.gov/27226707","citation_count":7,"is_preprint":false},{"pmid":"12930636","id":"PMC_12930636","title":"[Association between G-protein beta3 subunit (GNB(3)) gene C825T polymorphism, hypertension, insulin resistance and obesity].","date":"2003","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/12930636","citation_count":7,"is_preprint":false},{"pmid":"36896947","id":"PMC_36896947","title":"The role of NOS3 (rs2070744) and GNB3 (rs5443) genes' polymorphisms in endothelial dysfunction pathway and carotid intima-media thickness in hypertensive patients.","date":"2023","source":"General physiology and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/36896947","citation_count":6,"is_preprint":false},{"pmid":"35373932","id":"PMC_35373932","title":"Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity.","date":"2022","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35373932","citation_count":6,"is_preprint":false},{"pmid":"35489051","id":"PMC_35489051","title":"Endothelium function biomarkers and carotid intima-media thickness changes in relation to NOS3 (rs2070744) and GNB3 (rs5443) genes polymorphism in the essential arterial hypertension.","date":"2022","source":"Endocrine regulations","url":"https://pubmed.ncbi.nlm.nih.gov/35489051","citation_count":6,"is_preprint":false},{"pmid":"27114919","id":"PMC_27114919","title":"Association between GNB3 c.825C > T polymorphism and the risk of overweight and obesity: A meta-analysis.","date":"2016","source":"Meta gene","url":"https://pubmed.ncbi.nlm.nih.gov/27114919","citation_count":6,"is_preprint":false},{"pmid":"32391916","id":"PMC_32391916","title":"Lack of association between the GNB3 rs5443, HIF1A rs11549465 polymorphisms, physiological and functional characteristics.","date":"2020","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32391916","citation_count":6,"is_preprint":false},{"pmid":"26821322","id":"PMC_26821322","title":"Synergistic Effects of ACE Insertion/Deletion and GNB3 C825T Polymorphisms on the Efficacy of PDE-5 Inhibitor in Patients with Pulmonary Hypertension.","date":"2016","source":"Respiration; international review of thoracic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26821322","citation_count":6,"is_preprint":false},{"pmid":"19885780","id":"PMC_19885780","title":"GNB3 C825T polymorphism and elevated blood pressure.","date":"2009","source":"International journal of sports medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19885780","citation_count":6,"is_preprint":false},{"pmid":"16354603","id":"PMC_16354603","title":"GNB3 C825T polymorphism and response to anti-retroviral combination therapy in HIV-1-infected patients--a pilot study.","date":"2005","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/16354603","citation_count":6,"is_preprint":false},{"pmid":"24251036","id":"PMC_24251036","title":"Cognitive Functions across the GNB3 C825T Polymorphism in an Elderly Italian Population.","date":"2013","source":"Neurology research international","url":"https://pubmed.ncbi.nlm.nih.gov/24251036","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56024,"output_tokens":3300,"usd":0.108786,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10915,"output_tokens":3652,"usd":0.072938,"stage2_stop_reason":"end_turn"},"total_usd":0.181724,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"The C825T variant in exon 10 of GNB3 induces formation of a splice variant (Gβ3-s) in which nucleotides 498–620 of exon 9 are deleted, and this splice variant is associated with enhanced G-protein signal transduction activity in human cells and tissues.\",\n      \"method\": \"Molecular genotyping, splice variant characterization, functional signal transduction assays\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic link between SNP and splice variant described in multiple papers citing the original finding; single-lab origin but replicated in multiple subsequent studies referencing the same mechanism\",\n      \"pmids\": [\"9856980\", \"11927836\", \"21709600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Healthy normotensive carriers of the GNB3 825T allele show significantly enhanced vasoconstriction responses to endothelin-1, angiotensin II, and noradrenaline in the skin microcirculation in vivo, demonstrating that the polymorphism modulates GPCR-mediated vascular tone.\",\n      \"method\": \"Laser Doppler flowmetry in vivo, pharmacological dose-response curves, NOS inhibition and alpha2-adrenoceptor antagonism to dissect mechanism\",\n      \"journal\": \"Pharmacogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo physiological measurement with pharmacological dissection; single lab, multiple agonists and receptor pathway inhibitors\",\n      \"pmids\": [\"12172218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The GNB3 825T allele is associated with enhanced nitroglycerin-induced venodilation in healthy men in vivo, suggesting G-protein (pertussis toxin-sensitive pathway) involvement in nitroglycerin signal transduction.\",\n      \"method\": \"Linear variable transducer technique measuring dorsal hand vein compliance; dose-response curves to nitroglycerin in subjects stratified by GNB3 genotype\",\n      \"journal\": \"Clinical Pharmacology and Therapeutics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method, pharmacological association study without direct biochemical confirmation of mechanism\",\n      \"pmids\": [\"14586390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The GNB3 825CC genotype (lower signaling) is associated with enhanced platelet aggregation in response to low concentrations of GPCR agonists (ADP, thromboxane agonist U46619, epinephrine), and this effect is further enhanced cooperatively by the GPIIIa Pl(A2) allele.\",\n      \"method\": \"Turbidometric platelet aggregation assay with multiple agonists; genotyping by Pyrosequencing and restriction analysis in 150 individuals\",\n      \"journal\": \"Thrombosis Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional ex vivo platelet assay with multiple agonists and combinatorial genotype analysis; single lab\",\n      \"pmids\": [\"12818251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The GNB3 825T allele is associated with impaired insulin-mediated venodilation in young healthy men in vivo, demonstrating that GNB3 genotype influences vascular insulin signaling.\",\n      \"method\": \"Linear variable transducer technique measuring dorsal hand vein compliance in response to insulin infusion, stratified by GNB3 C825T genotype; NOS3 genotype used as co-variable\",\n      \"journal\": \"Clinical Pharmacology and Therapeutics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method, functional vascular pharmacology study; no direct biochemical mechanism demonstrated\",\n      \"pmids\": [\"15961981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In rge chickens, the D153del mutation in GNB3 targets the Gβ3 protein to early degradation (demonstrated by cycloheximide chase in COS-7 cells), leads to tissue-specific alterations in cGMP, cAMP, MAPK, AKT, and GRK2 phosphorylation cascades, and causes glomerulomegaly and tubulointerstitial inflammation in the kidney.\",\n      \"method\": \"Recombinant GNB3 constructs transfected into COS-7 cells with cycloheximide chase; secondary messenger quantification (cGMP, cAMP); kinase phosphorylation assays (MAPK, AKT, GRK2); kidney histochemistry\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutant vs wild-type protein plus cycloheximide chase establishing protein stability, combined with downstream signaling measurements and histopathological validation in vivo\",\n      \"pmids\": [\"21887213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GNB3 is highly expressed in brain, retina, and heart ventricles; transgenic mice carrying an extra copy of GNB3 develop excess intraabdominal fat accumulation and weigh significantly more than wild-type littermates, establishing a causal role for GNB3 overexpression in obesity.\",\n      \"method\": \"BAC transgenic mouse model with extra copy of GNB3; body weight and body composition measurements compared to wild-type littermates; tissue expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic animal model with direct overexpression and quantitative metabolic phenotyping; replicated and extended in a subsequent study (PMID 29206867)\",\n      \"pmids\": [\"23980137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Gβ3-null (GNB3−/−) mice show bradycardia during tail-cuff blood pressure measurements but normal body weight, metabolism, and blood pressure, including after angiotensin II infusion; isolated Gβ3-null hearts respond equivalently to muscarinic and β-adrenergic receptor stimulation, indicating Gβ3 is not directly involved in GPCR-controlled cardiac pacemaker activity.\",\n      \"method\": \"GNB3 knockout mouse model; metabolic phenotyping; tail-cuff blood pressure and heart rate measurements; angiotensin II infusion hypertension model; isolated perfused heart preparations; pharmacological receptor stimulation\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout model with multiple orthogonal metabolic and cardiac physiological readouts including isolated organ preparations\",\n      \"pmids\": [\"25093805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Biallelic loss-of-function mutations in GNB3 (compound heterozygous deletion/nonsense or homozygous nonsense/missense) cause a unique form of autosomal-recessive congenital stationary night blindness with dual anomaly: ON bipolar cell signaling defect and reduced cone sensitivity, establishing GNB3 as required for both cone phototransduction and ON bipolar cell signaling in humans.\",\n      \"method\": \"Whole-exome sequencing of affected families; ERG characterization of affected individuals; mutational screening of 58 CSNB subjects\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human genetics with multiple independent loss-of-function alleles confirmed by sequencing and functional ERG characterization; consistent with mouse knockout phenotype\",\n      \"pmids\": [\"27063057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A homozygous GNB3 nonsense mutation (c.124C>T; p.Arg42Ter) causes recessive inherited retinal disease in humans characterized by nystagmus and macular disturbance, consistent with GNB3 being essential for cone photoreceptor and ON-bipolar cell function.\",\n      \"method\": \"Whole-exome sequencing; detailed retinal phenotyping including retinal imaging\",\n      \"journal\": \"JAMA Ophthalmology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single case with definitive loss-of-function allele and phenotypic characterization; consistent with parallel human genetics study (PMID 27063057)\",\n      \"pmids\": [\"27281386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Transgenic mice carrying an extra copy of the human GNB3 825T risk allele develop increased adiposity, glucose intolerance, elevated fasting insulin and C-peptide (type 2 diabetes features), dyslipidemia, and lower UCP1 expression in white adipose tissue, without increased food intake or altered activity levels; this implicates GNB3 overexpression in dysregulated thermogenesis as a mechanism for obesity.\",\n      \"method\": \"BAC transgenic mouse model carrying human GNB3 825T allele; metabolic cage studies; glucose tolerance tests; plasma metabolite measurements; UCP1 gene expression in adipose tissue; behavioral battery\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — controlled transgenic animal model with multiple orthogonal metabolic readouts and mechanistic follow-up (UCP1 expression), replicating and extending prior mouse overexpression study (PMID 23980137)\",\n      \"pmids\": [\"29206867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The GNB3 825CC genotype is associated with significantly enhanced platelet aggregation in response to multiple GPCR agonists (TRAP, ADP, TXA2 agonist U46619, epinephrine) in whole blood impedance aggregometry, independently of the GPIIIa Pl(A) polymorphism, establishing GNB3 genotype as an independent determinant of platelet GPCR signaling.\",\n      \"method\": \"Impedance aggregometry (Multiplate) in whole blood from 143 individuals; multiple agonist concentrations; genotyping by Pyrosequencing and restriction analysis; multiple regression analysis\",\n      \"journal\": \"Pharmacogenetics and Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional ex vivo platelet assay with multiple agonists and regression analysis; single lab, replicates prior finding (PMID 12818251)\",\n      \"pmids\": [\"22082654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Molecular modelling of GNB3 pre-mRNA secondary structures reveals marked differences between the C-haplotype and T-haplotype that may account for alternative splicing predominantly observed with the T-haplotype; six novel SNPs were identified defining two major GNB3 haplotypes across ethnic populations.\",\n      \"method\": \"Systematic gene sequencing for SNP discovery; genotyping in Caucasian, African, and Asian populations; computational RNA secondary structure modelling\",\n      \"journal\": \"Pharmacogenetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational modelling of RNA structure without experimental validation of splicing mechanism\",\n      \"pmids\": [\"11927836\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNB3 encodes the β3 subunit of heterotrimeric G proteins; a C825T variant in exon 10 drives alternative splicing to produce a truncated Gβ3-s variant with enhanced signal transduction, while biallelic loss-of-function mutations cause autosomal-recessive congenital stationary night blindness by disrupting both cone phototransduction and ON-bipolar cell signaling; GNB3 overexpression in transgenic mice causes obesity and metabolic syndrome associated with impaired thermogenesis (reduced UCP1 in white adipose tissue), whereas GNB3 knockout mice are metabolically normal but show bradycardia; the 825T allele also modulates GPCR-mediated vascular responses (enhanced vasoconstriction to endothelin-1, angiotensin II, and noradrenaline) and platelet aggregation via downstream G-protein signaling pathways.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNB3 encodes the Gβ3 subunit of heterotrimeric G proteins and functions as a transducer of GPCR signaling across vascular, hematologic, retinal, and metabolic tissues [#5, #6]. A clinically important C825T variant in exon 10 drives an alternative splicing event that deletes exon 9 nucleotides 498–620 to generate a truncated Gβ3-s variant associated with enhanced signal transduction [#0]. This altered signaling output is reflected physiologically: 825T carriers show enhanced GPCR-mediated vasoconstriction to endothelin-1, angiotensin II, and noradrenaline [#1], while the 825CC genotype is associated with enhanced platelet aggregation to GPCR agonists including ADP, U46619, and epinephrine, independently of the GPIIIa Pl(A) polymorphism [#3, #11]. Loss-of-function studies establish the protein's essential roles: in chickens, the D153del mutation destabilizes Gβ3 and perturbs cGMP, cAMP, MAPK, AKT, and GRK2 signaling [#5], and in humans biallelic loss-of-function mutations cause autosomal-recessive congenital stationary night blindness with combined cone phototransduction and ON-bipolar cell signaling defects [#8, #9]. GNB3 dosage controls metabolism: transgenic mice carrying an extra copy develop obesity, increased adiposity, and glucose intolerance with reduced UCP1 in white adipose tissue, implicating impaired thermogenesis, whereas Gβ3-null mice are metabolically normal but bradycardic [#6, #10, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the molecular consequence of the common C825T variant, answering how a synonymous-region SNP could alter G-protein function by linking it to a truncated splice variant with enhanced signaling.\",\n      \"evidence\": \"Molecular genotyping with splice variant characterization and functional signal transduction assays in human cells/tissues\",\n      \"pmids\": [\"9856980\", \"11927836\", \"21709600\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical mechanism by which Gβ3-s enhances signaling not resolved\", \"Quantitative contribution of the splice variant in different tissues unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Tested whether the C825T variant produces measurable in vivo vascular consequences, showing it modulates GPCR-mediated vascular tone across multiple agonist pathways.\",\n      \"evidence\": \"Laser Doppler flowmetry in vivo with pharmacological dose-response and receptor pathway inhibition in 825T carriers\",\n      \"pmids\": [\"12172218\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish a direct biochemical link between Gβ3-s and the enhanced vasoconstriction\", \"Single lab; receptor-specific contributions not fully dissected\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Sought a structural basis for the genotype-specific splicing, proposing that haplotype-dependent pre-mRNA secondary structure differences favor exon skipping with the T-haplotype.\",\n      \"evidence\": \"SNP discovery, multi-ethnic genotyping, and computational RNA secondary structure modelling\",\n      \"pmids\": [\"11927836\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only; no experimental validation of the proposed splicing mechanism\", \"Causal SNP within the haplotype not isolated functionally\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended the functional readout of GNB3 genotype to platelets, showing the 825CC genotype enhances GPCR-agonist-induced aggregation and cooperates with the GPIIIa Pl(A2) allele.\",\n      \"evidence\": \"Turbidometric platelet aggregation with multiple agonists and combinatorial genotyping in 150 individuals\",\n      \"pmids\": [\"12818251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking genotype to platelet signaling output not biochemically defined\", \"Direction of effect (CC enhanced) contrasts with vascular 825T findings and is not mechanistically reconciled\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Probed whether GNB3 genotype affects nitroglycerin signaling in veins, associating 825T with enhanced venodilation via a pertussis toxin-sensitive pathway.\",\n      \"evidence\": \"Dorsal hand vein compliance dose-response to nitroglycerin stratified by genotype\",\n      \"pmids\": [\"14586390\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single-lab pharmacological association without direct biochemical confirmation\", \"Pathway involvement inferred, not demonstrated at the protein level\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Tested whether GNB3 genotype influences vascular insulin signaling, associating 825T with impaired insulin-mediated venodilation.\",\n      \"evidence\": \"Dorsal hand vein compliance to insulin infusion stratified by genotype with NOS3 as covariate\",\n      \"pmids\": [\"15961981\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single method, no direct biochemical mechanism\", \"Link to systemic metabolic phenotypes not established here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided direct evidence that a GNB3 mutation acts via protein destabilization and broad signaling perturbation, moving beyond association to a causal cellular and tissue mechanism.\",\n      \"evidence\": \"Recombinant wild-type vs D153del constructs in COS-7 with cycloheximide chase, second-messenger and kinase phosphorylation assays, and kidney histopathology in rge chickens\",\n      \"pmids\": [\"21887213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cascade alterations are correlative downstream readouts, not mapped to specific effectors\", \"Chicken-specific findings not directly validated in mammalian retina or kidney\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that GNB3 gene dosage causally drives obesity, demonstrating a metabolic role independent of the human genetic associations.\",\n      \"evidence\": \"BAC transgenic mouse with extra GNB3 copy, body weight and composition phenotyping, tissue expression analysis\",\n      \"pmids\": [\"23980137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism connecting Gβ3 dosage to adiposity not defined in this study\", \"Tissue site of action for the metabolic effect not localized\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Used a clean knockout to define what Gβ3 is dispensable for, showing it is not required for normal metabolism or GPCR-controlled cardiac pacemaking, isolating bradycardia as its loss-of-function cardiac phenotype.\",\n      \"evidence\": \"GNB3-null mice with metabolic and blood pressure phenotyping, angiotensin II hypertension model, and isolated perfused heart pharmacology\",\n      \"pmids\": [\"25093805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of bradycardia not explained\", \"Asymmetry between overexpression (obesity) and knockout (normal metabolism) phenotypes unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established GNB3 as a human disease gene by showing biallelic loss-of-function causes congenital stationary night blindness with a dual retinal signaling defect, defining its essential role in cone phototransduction and ON-bipolar cell signaling.\",\n      \"evidence\": \"Whole-exome sequencing of affected families with ERG characterization and mutational screening; independent case with p.Arg42Ter nonsense allele and retinal imaging\",\n      \"pmids\": [\"27063057\", \"27281386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Distinct molecular pathways in cones versus ON-bipolar cells not separated\", \"Genotype-phenotype correlation across alleles limited by case numbers\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Refined the obesity mechanism by linking GNB3 825T overexpression to impaired thermogenesis, identifying reduced adipose UCP1 as a candidate driver of the metabolic syndrome phenotype.\",\n      \"evidence\": \"BAC transgenic mice carrying human GNB3 825T allele with metabolic cage studies, glucose tolerance tests, plasma metabolites, UCP1 expression, and behavioral battery\",\n      \"pmids\": [\"29206867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal chain from Gβ3 dosage to UCP1 downregulation not mechanistically traced\", \"Cell-autonomous versus systemic origin of the thermogenic defect unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the C825T-encoded Gβ3-s variant biochemically enhances G-protein signaling, and how the same gene's dosage and loss-of-function produce divergent tissue-specific phenotypes (vasculature, platelets, retina, metabolism), remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural or reconstitution data defining Gβ3-s effector coupling\", \"Direction-of-effect discrepancies between vascular (825T) and platelet (825CC) phenotypes unexplained\", \"Mechanism linking Gβ3 dosage to adipose UCP1 and thermogenesis not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [5, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 3, 5, 11]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [6, 10]}\n    ],\n    \"complexes\": [\"heterotrimeric G protein\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}